Abstract:An immunochromatographic test for the rapid determination of immunoglobulin M (IgM) and IgG antibodies to Burkholderia pseudomallei was evaluated by using sera from bacteriologically confirmed melioidosis patients and high-risk and clinically suspected patients, along with disease control groups. The sensitivities were 100 and 93% for the IgG and IgM tests, respectively, while the specificity was 95% for both assays. The test was rapid and simple to perform, with results obtained in 10 min.
“…Recent studies investigating the potential of ELISA and related strategies for the serodiagnosis of melioidosis using various antigen preparations have provided varying results generally with poor sensitivities and specificities (Ashdown et al , 1989; Cuzzubbo et al , 2000; Chenthamarakshan et al , 2001; O'Brien et al , 2004; Chua et al , 2005; Chantratita et al , 2007; Druar et al , 2008). Further, some of these studies have used crude antigens, which increases the potential for laboratory‐acquired infection and inconsistencies in their preparation.…”
Section: Discussionmentioning
confidence: 99%
“…As a result of these limitations, indirect fluorescent‐antibody assays (IFAs) (Ashdown, 1981) have been used, but require a fluorescent microscope, which may not be available in resource‐poor regions of endemicity. More recently, enzyme‐linked immunosorbent assays (ELISAs), and related serodiagnostic strategies, are becoming increasingly considered as diagnostic tools for melioidosis (Ashdown et al , 1989; Cuzzubbo et al , 2000; Chenthamarakshan et al , 2001; O'Brien et al , 2004; Chua et al , 2005; Chantratita et al , 2007; Druar et al , 2008). Many of these also use crude antigen preparations.…”
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic to Southeast Asia and northern Australia. Clinical manifestations of the disease are diverse, ranging from chronic localized infection to acute septicaemia, with death occurring within 24-48 h after the onset of symptoms. Definitive diagnosis of melioidosis involves bacterial culture and identification, with results obtained within 3-4 days. This delayed diagnosis is a major contributing factor to high mortality rates. Rapid diagnosis is vital for successful management of the disease. This study describes the purification and evaluation of three recombinant antigenic proteins, BPSL0972, BipD and OmpA from B. pseudomallei 08, for their potential in the serodiagnosis of melioidosis using an indirect enzyme-linked immunosorbent assay (ELISA) method. The recombinant proteins were evaluated using 74 serum samples from culture-confirmed melioidosis patients from Malaysia, Thailand and Australia. In addition, 62 nonmelioidosis controls consisting of serum samples from clinically suspected melioidosis patients (n = 20) and from healthy blood donors from an endemic region (n = 18) and a nonendemic region (n = 24) were included. The indirect ELISAs using BipD and BPSL0972 as antigens demonstrated poor to moderate sensitivities (42% and 51%, respectively) but good specificity (both 100%). In contrast, the indirect ELISA using OmpA as an antigen achieved 95% sensitivity and 98% specificity. These results highlight the potential for OmpA to be used in the serodiagnosis of melioidosis in an endemic area.
“…Recent studies investigating the potential of ELISA and related strategies for the serodiagnosis of melioidosis using various antigen preparations have provided varying results generally with poor sensitivities and specificities (Ashdown et al , 1989; Cuzzubbo et al , 2000; Chenthamarakshan et al , 2001; O'Brien et al , 2004; Chua et al , 2005; Chantratita et al , 2007; Druar et al , 2008). Further, some of these studies have used crude antigens, which increases the potential for laboratory‐acquired infection and inconsistencies in their preparation.…”
Section: Discussionmentioning
confidence: 99%
“…As a result of these limitations, indirect fluorescent‐antibody assays (IFAs) (Ashdown, 1981) have been used, but require a fluorescent microscope, which may not be available in resource‐poor regions of endemicity. More recently, enzyme‐linked immunosorbent assays (ELISAs), and related serodiagnostic strategies, are becoming increasingly considered as diagnostic tools for melioidosis (Ashdown et al , 1989; Cuzzubbo et al , 2000; Chenthamarakshan et al , 2001; O'Brien et al , 2004; Chua et al , 2005; Chantratita et al , 2007; Druar et al , 2008). Many of these also use crude antigen preparations.…”
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic to Southeast Asia and northern Australia. Clinical manifestations of the disease are diverse, ranging from chronic localized infection to acute septicaemia, with death occurring within 24-48 h after the onset of symptoms. Definitive diagnosis of melioidosis involves bacterial culture and identification, with results obtained within 3-4 days. This delayed diagnosis is a major contributing factor to high mortality rates. Rapid diagnosis is vital for successful management of the disease. This study describes the purification and evaluation of three recombinant antigenic proteins, BPSL0972, BipD and OmpA from B. pseudomallei 08, for their potential in the serodiagnosis of melioidosis using an indirect enzyme-linked immunosorbent assay (ELISA) method. The recombinant proteins were evaluated using 74 serum samples from culture-confirmed melioidosis patients from Malaysia, Thailand and Australia. In addition, 62 nonmelioidosis controls consisting of serum samples from clinically suspected melioidosis patients (n = 20) and from healthy blood donors from an endemic region (n = 18) and a nonendemic region (n = 24) were included. The indirect ELISAs using BipD and BPSL0972 as antigens demonstrated poor to moderate sensitivities (42% and 51%, respectively) but good specificity (both 100%). In contrast, the indirect ELISA using OmpA as an antigen achieved 95% sensitivity and 98% specificity. These results highlight the potential for OmpA to be used in the serodiagnosis of melioidosis in an endemic area.
“…A geometric antibody index for IgM antibody in the sera of the melioidosis cases was significantly higher in cases compared with that of the noncase controls. In another study by some of the same authors, a rapid test for IgG and IgM was shown to have clinical utility (Cuzzubbo et al, 2000). A study with the intent of evaluating the utility of an IgG assay compared with other assays illustrates how the clinical and temporal context must be integrated for interpretation (Dharakul et al, 1997).…”
Section: Considerations and Concerns Raised By Analysis Of Other Infementioning
“…A geometric antibody index for IgM antibody in sera of melioidosis cases was significantly higher in cases compared with that of noncase controls. In another study, a rapid test for IgG and IgM was shown to have clinical utility (41). A study with the intent of evaluating the utility of an IgG assay compared with other assays illustrates how the clinical and temporal context must be integrated for interpretation (42).…”
Section: Considerations and Concerns Raised By Analysis Of Other Infementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.